IGFSX | RWIEX | IGFSX / RWIEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 23 years | - |
Gain YTD | 3.257 | 3.931 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 291M | 129B | 0% |
Annual Yield % from dividends | 0.31 | 1.68 | 18% |
Returns for 1 year | 0.28 | 11.83 | 2% |
Returns for 3 years | -13.40 | 13.81 | -97% |
Returns for 5 years | -8.61 | 31.45 | -27% |
Returns for 10 years | -1.92 | 48.26 | -4% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 68.82 | 0.02 | +0.03% |
Janus Henderson Global Life Sciences T | |||
GCSAX | 27.17 | N/A | N/A |
Goldman Sachs Small Cap Eq Insghts A | |||
KMDIX | 30.98 | N/A | N/A |
Keeley Mid Cap Dividend Value I | |||
LOAGX | 14.35 | N/A | N/A |
Lord Abbett International Growth F3 | |||
WSGAX | 13.09 | -0.05 | -0.38% |
Macquarie Small Cap Growth A |